1MicroRNAs as diagnostic markers and therapeutic targets for traumatic brain injuryINVITED REVIEWS1749-1761
2Interferon regulatory factor 2 binding protein 2: a new player of the innate immune response for stroke recoveryINVITED REVIEWS1762-1764
6The role of general anesthetics and the mechanisms of hippocampal and extra-hippocampal dysfunctions in the genesis of postoperative cognitive dysfunctionINVITED REVIEWS1780-1785
7Design and criteria of electrospun fibrous scaffolds for the treatment of spinal cord injuryINVITED REVIEWS1786-1790
9Pathophysiology of periventricular leukomalacia: what we learned from animal modelsPERSPECTIVES1795-1796
10DJ-1 as a deglycating enzyme: a unique function to explain a multifaceted protein?PERSPECTIVES1797-1798
12Should we have a guard against therapeutic nihilism for patients with severe traumatic brain injury?PERSPECTIVES1801-1803
13Targeting inflammation to reduce brain injury in growth restricted newborns: a potential treatment?PERSPECTIVES1804-1806
14Targeting mitoNEET with pioglitazone for therapeutic neuroprotection after spinal cord injuryPERSPECTIVES1807-1808
16Therapeutic capacities of human and mouse skeletal muscle-derived stem cells for a long gap peripheral nerve injuryPERSPECTIVES1811-1813
17Targeting transcriptional regulators to regenerate midbrain dopaminergic axons in Parkinson's diseaseRESEARCH ARTICLES1814-1815
18Influence of vascular endothelial growth factor and radiation on gap junctional intercellular communication in glioblastoma multiforme cell linesRESEARCH ARTICLES1816-1822
19Leap Motion-based virtual reality training for improving motor functional recovery of upper limbs and neural reorganization in subacute stroke patientsRESEARCH ARTICLES1823-1831
20Activation of the Akt/mTOR signaling pathway: a potential response to long-term neuronal loss in the hippocampus after sepsisRESEARCH ARTICLES1832-1842
